CIK: 0001664974 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $58,507 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | 3,875 | $59 | 0.1% | $5.56 | +254.7% | — | G76279101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EVLV | Evolv Technologies Holdings, Inc. | 4,590,000 (-8.2%) | $32,864 (-12.9%) | 56.2% | $5.61 | +26.7% | COM CL A | 30049H102 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals, Inc. | 5,941,120 | $24,299 | 41.5% | $18.82 | -73.7% | CL A | 75629V104 |
| — | Mind Medicine (MindMed) Inc. | 100,350 | $1,344 | 2.3% | $3.17 | — | COM NEW | 60255C885 |